Polyrizon Ltd. Ordinary Shares (PLRZ)

Polyrizon Ltd. Ordinary Shares (PLRZ) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $24.9M; returns 1 day +0.1%, 1 week -12.7%, 1 year +34.6%.

Polyrizon Ltd. (PLRZ) is a development-stage biotech company specializing in intranasal hydrogel sprays designed to prevent viruses and allergens from interacting with nasal epithelial tissue. Their Capture and Contain (C&C) technology uses a hydrogel-based shield in the nasal cavity, acting as a biological mask.

Groups PLRZ belongs to

• Recent Reverse Splits
• Israel Companies
• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Medical Devices
• Infectious Diseases
• Israel
• Biopharmaceutical

PLRZ financial model: income statement, cash flow and balance sheet